Literature DB >> 9258521

The PREMAP Study: prevalence and risk factors of dementia and clinically diagnosed Alzheimer's disease in Provence, France. Prevalence of Alzheimer's Disease in Provence.

Y Obadia1, M Rotily, A Degrand-Guillaud, J Guelain, M Ceccaldi, C Severo, M Poncet, A Alperovitch.   

Abstract

The PREMAP Study investigated the prevalence and risk factors of dementia and Alzheimer's Disease (AD) in a random sample of 1062 residents 70 year old or more, living in south-eastern France (private homes and institutions). All persons living in institutions for the elderly (n = 258) and community dwellers (n = 804) scoring less than 24 points on the MMSE (18.4%) were invited to undergo a medical evaluation at home by a qualified neurologist using the CERAD battery. We found 177 cases of dementia (9.2%), including 82 cases of AD (5.5%). Prevalence of AD increased significantly with age and was higher among women (OR: 4.24) and persons with no formal educational level (OR: 2.47). While a MMS score less than 24 was more frequent among persons with a foreign native language (OR: 3.05), the OR and AD was not significantly associated with native language. The proportion of AD among persons suffering from senile dementia was 45% among elderly living in institutions and 69% among those living in the community. Prevalence rates in south-eastern France are similar to the average rates for Europe. This study underlines the need to investigate the relationships between native language, MMSE and AD on the one hand, and the link between a low MMSE score and institutionalisation of patients suffering from AD on the other.

Entities:  

Mesh:

Year:  1997        PMID: 9258521     DOI: 10.1023/a:1007300305507

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  18 in total

1.  [Influence of educational status on a screening test for dementia, the Mini-Mental State Examination].

Authors:  M J Dealberto; M Gagnon; P Barberger-Gateau; J F Dartigues; A Alperovitch
Journal:  Rev Epidemiol Sante Publique       Date:  1992       Impact factor: 1.019

2.  [Survey methodology in the prevalence of Alzheimer's disease in the Rhône delta].

Authors:  A Degrand-Guillaud; Y Obadia; J Guélain
Journal:  Rev Epidemiol Sante Publique       Date:  1991       Impact factor: 1.019

3.  [Logistics regression in epidemiology. II].

Authors:  J Bouyer
Journal:  Rev Epidemiol Sante Publique       Date:  1991       Impact factor: 1.019

4.  Depressive symptomatology and cognitive functioning: an epidemiological survey in an elderly community sample in France.

Authors:  R Fuhrer; T C Antonucci; M Gagnon; J F Dartigues; P Barberger-Gateau; A Alperovitch
Journal:  Psychol Med       Date:  1992-02       Impact factor: 7.723

5.  Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

Authors:  D A Evans; H H Funkenstein; M S Albert; P A Scherr; N R Cook; M J Chown; L E Hebert; C H Hennekens; J O Taylor
Journal:  JAMA       Date:  1989-11-10       Impact factor: 56.272

6.  A community-based study of dementia: the Rotterdam Elderly Study.

Authors:  M M Breteler; F A van den Ouweland; D E Grobbee; A Hofman
Journal:  Neuroepidemiology       Date:  1992       Impact factor: 3.282

7.  The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group.

Authors:  A Hofman; W A Rocca; C Brayne; M M Breteler; M Clarke; B Cooper; J R Copeland; J F Dartigues; A da Silva Droux; O Hagnell
Journal:  Int J Epidemiol       Date:  1991-09       Impact factor: 7.196

8.  Prevalence of Alzheimer's disease in a retirement community.

Authors:  R I Pfeffer; A A Afifi; J M Chance
Journal:  Am J Epidemiol       Date:  1987-03       Impact factor: 4.897

9.  Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study.

Authors:  D L Bachman; P A Wolf; R Linn; J E Knoefel; J Cobb; A Belanger; R B D'Agostino; L R White
Journal:  Neurology       Date:  1992-01       Impact factor: 9.910

10.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

View more
  6 in total

Review 1.  Are cognitively impaired individuals adequately represented in community surveys? Recruitment challenges and strategies to facilitate participation in community surveys of older adults. A review.

Authors:  S G Riedel-Heller; A Busse; M C Angermeyer
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

Review 2.  [Cognitive reserve and its relevance for the prevention and diagnosis of dementia].

Authors:  R Perneczky; P Alexopoulos; G Schmid; C Sorg; H Förstl; J Diehl-Schmid; A Kurz
Journal:  Nervenarzt       Date:  2011-03       Impact factor: 1.214

3.  Epidemiology of aging.

Authors:  Luigi Ferrucci; Francesco Giallauria; Jack M Guralnik
Journal:  Radiol Clin North Am       Date:  2008-07       Impact factor: 2.303

4.  Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years.

Authors:  Gerda G Fillenbaum; Gerald van Belle; John C Morris; Richard C Mohs; Suzanne S Mirra; Patricia C Davis; Pierre N Tariot; Jeremy M Silverman; Christopher M Clark; Kathleen A Welsh-Bohmer; Albert Heyman
Journal:  Alzheimers Dement       Date:  2008-03       Impact factor: 21.566

5.  Comparative Epidemiological Investigation of Alzheimer's Disease and Colorectal Cancer: The Possible Role of Gastrointestinal Conditions in the Pathogenesis of AD.

Authors:  Tianlang Zhang; YaRu Han; JianYi Wang; Deren Hou; Hao Deng; Yun L Deng; Zhi Song
Journal:  Front Aging Neurosci       Date:  2018-09-28       Impact factor: 5.750

6.  Prevalence of dementia and Alzheimer's disease in elders of nursing homes and a senior center of Durango City, Mexico.

Authors:  Cosme Alvarado-Esquivel; Ana Berthina Hernández-Alvarado; Rosa Oralia Tapia-Rodríguez; Angel Guerrero-Iturbe; Karina Rodríguez-Corral; Sergio Estrada Martínez
Journal:  BMC Psychiatry       Date:  2004-02-18       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.